MedTrace Logo

Tolerance to Light for Patients Suffering From Keratitis

NCT03586505 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-09-17

No results posted yet for this study

Summary

In order to develop an innovative device to study infectious keratitis, we need to illuminate the cornea of patients suffering from an infectious keratitis with red or near-infrared light. Because of technical reasons the shortest possible wavelength (red) presents advantages.

Conditions

  • Keratitis

Interventions

DEVICE

Light exposure

The 6 lights used randomly are : * 482nm =standard blue light illumination, * 650nm, * 675nm, * 700nm, * 750nm * 800nm

Sponsors & Collaborators

  • University of Saint-Etienne

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Gilles THURET, MD PhD · CHU de Saint-Etienne

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-03
Primary Completion
2019-08-07
Completion
2019-08-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03586505 on ClinicalTrials.gov